Autologous Decidual-like Natural Killer Cells Therapy(The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School)

N/A

Report date: 2025/11/19 20:01:17

Base Information

Drug NameAutologous Decidual-like Natural Killer Cells Therapy(The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Decidual-like NK cell therapy
Mechanisms of ActionNatural killer cell replacements
TargetsNot applicable
Therapy Area/IndicationsPre-EclampsiaAbortion, MissedAbortion, Habitual +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesThe Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
China Registration ClassN/A

Develop Information

Active CompaniesThe Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
Inactive CompaniesN/A
Active IndicationsPre-EclampsiaAbortion, MissedAbortion, Habitual +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A